mySalam Health Scheme a welcome relief for chronic disease patients



KOTA BHARU, Feb 12 -- The mySalam B40 National Health Protection Scheme initiated by the government has benefited many chronic disease and critical patients in Kelantan.

For chronic heart patient, Afrizam Arif, 40, said he received the one-off payment of RM8,000 and the maximum 14 days income replacement of RM50 per day after been hospitalised in January.

"I want to thank the government for providing the protection scheme which can ease the financial burden of patients while receiving further treatment to cover their travelling cost for appointments and physiotherapy session once a week.

"I've been warded at Hospital Universiti Sains Malaysia (HUSM) in August and at Raja Perempuan Zainab II Hospital (HRPZII) in October last year. I applied for mySalam at the end of December and I'm thankful because the money was deposited to my account in January," he told Bernama when met while undergoing physiotherapy session at HUSM’s Medical Rehabilitation Unit in Kubang Kerian, here today.

Afrizam also encouraged other chronic illness patients to fill up the claim form online and follow requirements set to expedite the scheme’s payment.

Meanwhile, HUSM mySalam kiosk crew, Maziah Ismail, 27, said kiosk personnel would assist applicants, especially from the low-income group (B40) who were unfamiliar with the system since applications had to be made online.



-- BERNAMA

 

 

 


 






HealthEdge


EXCLUSIVE

UKM Hospital To Conduct Study On Potential Therapy For Leukaemia

By Durratul Ain Ahmad Fuad

KUALA LUMPUR (Bernama) – A potentially effective treatment for patients with relapsed and refractory acute lymphoblastic leukaemia (ALL) is in the works.

ALL is a type of blood cancer in which the bone marrow makes too many lymphocytes, a type of white blood cell.

Universiti Kebangsaan Malaysia’s teaching facility Hospital Canselor Tuanku Muhriz (HCTM) is collaborating with Plutonet Sdn Bhd on a study and clinical trial involving the Chimeric Antigen Receptor-T Cell (CAR-T) therapy, a revolutionary treatment found to be effective for ALL patients who cannot be treated with chemotherapy or are immune to it.

read more ››

IN FOCUS

UMSC: Pain Management


In Focus : UMSC Raya Open House 2018

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 2

In Focus: UMSC Consultant Speaks Erectile Dysfunction Precursor For Heart Disease Part 1

In Focus : UMSC - Fatty Liver, The Silent Epidemic Part 2